ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in ImageneBio, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −4 vs. Q1 2026
- Shares held
- 6.23M
- +878.7K (+16.4%) vs. Q1 2026
- Total value
- $36.8M
- +$10.0M (+37.4%) vs. Q1 2026
- New holders
- 4
- 9 more added
- Sold out
- 8
- 12 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 24 | $142 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 70 | $425 | 0.00% | −223−76.1% | Reduced |
| GWM Advisors LLC | 160 | $944 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 464 | $2.74K | 0.00% | +462+23,100.0% | Added |
| Vanguard Global Advisers, LLC | 602 | $3.55K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 675 | $3.98K | 0.00% | −336−33.2% | Reduced |
| UBS Group AG | 6,879 | $40.6K | 0.00% | +1,451+26.7% | Added |
| Barclays PLC | 10,797 | $63.7K | 0.00% | −162−1.5% | Reduced |
| Northern Trust Corp | 11,271 | $66.5K | 0.00% | +11,271 | New |
| Goldman Sachs Group Inc | 15,485 | $91.4K | 0.00% | +4,027+35.1% | Added |
| Morgan Stanley | 16,678 | $98.4K | 0.00% | −1,661−9.1% | Reduced |
| Shay Capital LLC | 18,080 | $106.7K | 0.01% | −1,050−5.5% | Reduced |
| Aldebaran Capital, LLC | 18,124 | $106.9K | 0.08% | −442−2.4% | Reduced |
| Two Sigma Investments, LP | 19,900 | $117.4K | 0.00% | +19,900 | New |
| Rangeley Capital, LLC | 20,090 | $118.5K | 0.12% | −12,500−38.4% | Reduced |
| Vanguard Fiduciary Trust Co | 27,475 | $162.1K | 0.00% | +189+0.7% | Added |
| Sofinnova Investments, Inc. | 31,884 | $188.1K | 0.01% | 00.0% | Unchanged |
| HSBC Holdings PLC | 34,228 | $208.4K | 0.00% | −656−1.9% | Reduced |
| Nano Cap New Millennium Growth Fund L P | 50,000 | $295.0K | 0.23% | +20,000+66.7% | Added |
| NEA Management Company, LLC | 50,005 | $295.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 53,512 | $315.8K | 0.00% | −6,417−10.7% | Reduced |
| Citadel Advisors LLC | 55,610 | $328.1K | 0.00% | −68,735−55.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 66,666 | $393.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 86,930 | $512.9K | 0.00% | +5,234+6.4% | Added |
| BlackRock, Inc. | 135,090 | $797.0K | 0.00% | +5,876+4.5% | Added |
| Monashee Investment Management LLC | 192,344 | $1.13M | 1.90% | +192,344 | New |
| BML Capital Management, LLC | 200,730 | $1.18M | 0.68% | 00.0% | Unchanged |
| Trails Edge Capital Partners, LP | 282,004 | $1.66M | 0.26% | +282,004 | New |
| Vanguard Capital Management LLC | 320,518 | $1.89M | 0.00% | −4,637−1.4% | Reduced |
| RTW Investments, LP | 334,445 | $1.97M | 0.02% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 455,361 | $2.69M | 1.45% | 00.0% | Unchanged |
| Cable Car Capital LLC | 781,599 | $4.61M | 0.10% | +26,850+3.6% | Added |
| OrbiMed Advisors LLC | 909,269 | $5.36M | 0.10% | +530,713+140.2% | Added |
| Blue Owl Capital Holdings LP | 917,692 | $5.41M | 0.82% | −41,645−4.3% | Reduced |
| BVF Inc | 1,110,002 | $6.55M | 0.17% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −26,663−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −15,112−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,909−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,210−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −12,990−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −224−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −41−100.0% | Sold out |